Impact of Gender on Risk Stratification by Stress Echocardiography

American Journal of Medicine

Volumn 122, Issue 3, 2009, Pages 301-309

  Cortigiani, Lauro ^a   Sicari, Rosa ^b   Bigi, Riccardo ^c   Landi, Patrizia ^b   Bovenzi, Francesco ^a   Picano, Eugenio ^b  

^a CAMPO DI MARTE HOSPITAL   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Gender gap; Prognosis; Stress echocardiography; Women

Indexed keywords

DIPYRIDAMOLE; DOBUTAMINE;

ARTICLE; CORONARY ARTERY DISEASE; GENDER; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; STRESS ECHOCARDIOGRAPHY;

AGED; ANALYSIS OF VARIANCE; CORONARY ARTERY DISEASE; DIPYRIDAMOLE; ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; VASODILATOR AGENTS;

EID: 61549132045     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.11.003     Document Type: Article

References (40)

1. American Heart Association. Heart Disease and Stroke Statistics-2007 Update (2007), American Heart Association, Dallas, TX
2. Wenger N.K., Shaw L.J., and Vaccarino V. Coronary heart disease in women: update 2008. Clin Pharmacol Ther 83 (2008) 37-51
3. Mosca L., Manson J.E., Sutherland S.E., et al. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Circulation 96 (1997) 2468-2482
4. Mieres J.H., Shaw L.J., Arai A., et al., Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation 111 (2005) 682-696
5. Bigi R., and Cortigiani L. Stress testing in women: sexual discrimination or equal opportunity?. Eur Heart J 26 (2005) 423-425
6. Kwok Y., Kim C., Grady D., et al. A meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 83 (1999) 660-666
7. Masini M., Picano E., Lattanzi F., et al. High-dose dipyridamole-echocardiography test in women: correlation with exercise-electrocardiography test and coronary angiography. J Am Coll Cardiol 12 (1988) 682-685
8. Shaw L.J., Miller D.D., Romeis J.C., et al. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med 120 (1994) 559-566
9. Sawada S.G., Ryan T., Fineberg N.S., et al. Exercise echocardiographic detection of coronary artery disease in women. J Am Coll Cardiol 14 (1989) 1440-1447
10. Marwick T.H., Anderson T., Williams M.J., et al. Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol 26 (1995) 335-341
11. Ho Y.L., Wu C.C., Huang P.J., et al. Assessment of coronary artery disease in women by dobutamine stress echocardiography: comparison with stress thallium-201 single-photon emission computed tomography and exercise electrocardiography. Am Heart J 135 (1998) 655-662
12. Elhendy A., van Domburg R.T., Bax J.J., et al. Noninvasive diagnosis of coronary artery disease in women with limited exercise capacity: comparison of dobutamine stress echocardiography and 99mTc sestamibi single-photon emission CT. Chest 114 (1998) 1097-1104
13. Dionisopoulos P.N., Collins J.D., Smart S.C., et al. The value of dobutamine stress echocardiography for the detection of coronary artery disease in women. J Am Soc Echocardiogr 10 (1997) 811-817
14. Heupler S., Metha R., Lobo A., et al. Prognostic implications of exercise echocardiography in women with known or suspected coronary artery disease. J Am Coll Cardiol 30 (1997) 414-420
15. Cortigiani L., Dodi C., Paolini E.A., et al. Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease. J Am Coll Cardiol 32 (1998) 1975-1981
16. Davar J.I., Brull D.J., Bulugahipitiya S., et al. Prognostic value of negative dobutamine stress echo in women with intermediate probability of coronary artery disease. Am J Cardiol 83 (1999) 100-102
17. Dodi C., Cortigiani L., Masini M., et al. The incremental prognostic value of pharmacological stress echo over exercise electrocardiography in women with chest pain of unknown origin. Eur Heart J 22 (2001) 145-152
18. Cortigiani L., Gigli G., Vallebona A., et al. The stress echo prognostic gender gap. Eur J Echocardiogr 2 (2001) 132-138
19. Arruda-Olson A.M., Juracan E.M., Mahoney D.W., et al. Prognostic value of exercise echocardiography in 5,798 patients: is there a gender difference?. J Am Coll Cardiol 39 (2002) 625-631
20. Shaw L.J., Vassey C., Sawada S., et al. Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4,234 women and 6,898 men. Eur Heart J 26 (2005) 447-456
21. Biagini E., Elhendy A., Bax J.J., et al. Seven-year follow-up after dobutamine stress echocardiography. Impact of gender on prognosis. J Am Coll Cardiol 45 (2005) 93-97
22. Picano E., Landi P., Bolognese L., et al. Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: a large scale multicenter trial. Am J Med 11 (1993) 608-618
23. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part I: Diagnosis and Classification of Diabetes Mellitus. WHO/NCD/NCS/99.2 (1999), World Health Organization, Geneva
24. European Society of Hypertension-European Society of Cardiology. Guidelines for the management of arterial hypertension. J Hypertension 21 (2003) 1011-1053
25. National cholesterol education program expert panel. Third Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Full Report. World Wide Web; 2001. Available at http://www.nhlbi.nih.gov/guidelines/cholesterol/index.htm. Last accessed January 10, 2009.
26. Sicari R., Nihoyannopoulos P., Evangelista A., et al. Stress echocardiography expert consensus statement from the European Association of Echocardiography. Eur J Echocardiogr 9 (2008) 415-437
27. Lauer M.S., Blackstone E.H., Young J.B., and Topol E.J. Cause of death in clinical research: time for a reassessment?. J Am Coll Cardiol 34 (1999) 618-620
28. Pencina M.J., D'Agostino Sr. R.B., D'Agostino Jr. R.B., and Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27 (2008) 157-172
29. Daly C.A., De Stavola B., Sendon J.L., et al., Euro Heart Survey Investigators. Predicting prognosis in stable angina-results from the Euro heart survey of stable angina: prospective observational study. BMJ 332 (2006) 262-267
30. Greenland P., Reicher-Reiss H., Goldbourt U., Behar S., and Israeli SPRINT Investigators. In-hospital and 1-year mortality in 1,524 women after myocardial infarction: comparison with 4,315 men. Circulation 83 (1991) 484-491
31. Hochman J.S., Tamis J.E., Thompson T.D., et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. N Engl J Med 341 (1999) 226-232
32. Shaw L.J., Bairey Merz C.N., Pepine C.J., et al., WISE Investigators. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 47 3 Suppl (2006) S4-S20
33. Hochman J.S., and Tamis-Holland J.E. Acute coronary syndromes: does sex matter?. JAMA 288 (2002) 3161-3164
34. Glaser R., Herrmann H.C., Murphy S.A., et al. Benefit of an early invasive management strategy in women with acute coronary syndromes. JAMA 288 (2002) 3124-3129
35. Picano E., Molnaro S., and Pasanisi E. The diagnostic accuracy of pharmacological stress echocardiography for the assessment of coronary artery disease: a meta-analysis. Cardiovasc Ultrasound 6 (2008) 30
36. Gershlick A.H., de Belder M., Chambers J., et al. Role of non-invasive imaging in the management of coronary artery disease: an assessment of likely change over the next 10 years. A report from the British Cardiovascular Society Working Group. Heart 93 (2007) 423-431
37. Pingitore A., Picano E., Varga A., et al. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. J Am Coll Cardiol 34 (1999) 1769-1777
38. Schroeder K., Wieckhorst A., and Voller H. Comparison of the prognostic value of dipyridamole and dobutamine stress echocardiography in patients with known or suspected coronary artery disease. Am J Cardiol 79 (1997) 1516-1517
39. Minardi G., Disegni M., Manzara C., et al. Diagnostic and prognostic value of dipyridamole and dobutamine stress echocardiography in patients with acute myocardial infarction. Am J Cardiol 80 (1997) 847-851
40. Cortigiani L., Bigi R., Sicari R., et al. Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease. J Am Coll Cardiol 47 (2006) 605-610